Notice2022-28005
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 23, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 246 (Friday, December 23, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 246 (Friday, December 23, 2022)]
[Notices]
[Pages 78971-78973]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-28005]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-23-1318]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Requirement for Proof of COVID-19
Vaccination for Noncitizen, Nonimmigrant Air Passengers Arriving into
the United States from a Foreign Country'' to the Office of Management
and Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on July 5, 2022 to obtain comments from the
public and affected agencies. CDC received 5,935 comments related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary
[[Page 78972]]
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Requirement for Proof of COVID-19 Vaccination for Noncitizen,
Nonimmigrant Air Passengers Arriving into the United States from a
Foreign Country (OMB Control No. 0920-1318, Exp. 12/31/2022)--
Extension--National Center for Emerging Zoonotic and Infectious
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC), National
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division
of Global Migration and Quarantine (DGMQ) requests a two-year Extension
for the information collection: Requirement for Proof of COVID-19
Vaccination for Noncitizen, Nonimmigrant Air Passengers Arriving into
the United States from a Foreign Country. This information collection
is necessary to implement the Presidential Proclamation Advancing Safe
Resumption of Global Travel During the COVID-19 Pandemic and CDC's
Amended Order Implementing Presidential Proclamation on Advancing Safe
Resumption of Global Travel During the COVID-19 Pandemic.
Pursuant to Sections 1182(f) and 1185(a)(1) of Title 8, and Section
301 of Title 3, United States Code, on October 25, 2021, the President
issued a Proclamation (``the Proclamation'') titled, ``Advancing the
Safe Resumption of Global Travel During the COVID-19 Pandemic.'' With
this Proclamation, the President implemented a global suspension and
limitation on entry for noncitizens who are nonimmigrants (``noncitizen
nonimmigrants'') seeking to enter the United States by air travel and
who are not fully vaccinated against COVID-19. The Proclamation
directs, in part, the Secretary of Health and Human Services (HHS),
through the Director of the Centers for Disease Control and Prevention
(CDC), to implement the Proclamation as it applies to public health in
accordance with appropriate public health protocols and consistent with
CDC's independent public health judgment.
CDC issued the Order Implementing the Presidential Proclamation on
Advancing Safe Resumption of Global Travel During the COVID-19 Pandemic
on October 25, 2021. Beginning on November 8, 2021, CDC's Order
required noncitizen nonimmigrants to show proof of being fully
vaccinated against COVID-19 with: (1) one of the vaccines approved (or
authorized for emergency use) by the U.S. Food and Drug Administration
(FDA); (2) a vaccine listed for emergency use by the World Health
Organization (WHO); or (3) a combination of vaccines as specified in
CDC Technical Instructions.
Air passengers who are noncitizen nonimmigrants must provide proof
of COVID-19 vaccination and attest to the truthfulness of the proof of
vaccination. Airlines must also confirm that the proof of vaccination
matches the passengers' identity, as instructed by the airline before
being allowed to board a flight to the United States. The Order allows
some exceptions to this requirement. Most categories of exceptions
require the individual to attest to taking certain measures after U.S.
arrival, specifically, getting tested 3-5 days after arrival and
isolating if they test positive or develop symptoms. An additional
category of exceptions requires the individual to attest to getting
fully vaccinated against COVID-19 if staying more than 60 days.
CDC issued an amended Order on October 30, 2021, and on April 4,
2022. The Amended Vaccination Order signed on April 4, 2022 superseded
the previous Order signed by the CDC Director on October 30, 2021, and
continues to implement the President's direction. CDC requests OMB
approval for an estimated 68,005,000 annual burden hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Noncitizen Nonimmigrant Air Passenger. Section 2 of Combined 60,000,000 1 1
Passenger Disclosure
and Attestation to the
United States of
America.
Airline Desk Agent.................... Combined Passenger 60,000,000 1 8/60
Disclosure and
Attestation to the
United States of
America.
Noncitizen Nonimmigrant Air Passenger. Request Humanitarian or 1,290 1 2
Emergency Exception to
Proof of Vaccination
Requirement--(No form).
Air Traveler (for illness or death Air Travel Illness or 10,000 1 15/60
investigation). Death Investigation or
Traveler Follow-up Form.
----------------------------------------------------------------------------------------------------------------
[[Page 78973]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-28005 Filed 12-22-22; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on December 23, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.